| Title |
A Systematic Review of Reported Cost for Smear and Culture Tests during Multidrug-Resistant Tuberculosis Treatment
|
|---|---|
| Published in |
PLOS ONE, February 2013
|
| DOI | 10.1371/journal.pone.0056074 |
| Pubmed ID | |
| Authors |
Chunling Lu, Qing Liu, Aartik Sarma, Christopher Fitzpatrick, Dennis Falzon, Carole D. Mitnick |
| Abstract |
In 2011, World Health Organization revised its recommendation for microbiological monitoring during treatment for multidrug-resistant tuberculosis (MDR-TB) by increasing the frequency of culture examination from quarterly to monthly after culture conversion. Implementing the recommendation requires substantial additional investment in laboratory infrastructure. The objective of this review is to provide cost evidence that is needed for national TB programs to budget for optimal monitoring strategies. |
Mendeley readers
The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 2% |
| India | 1 | <1% |
| Brazil | 1 | <1% |
| Rwanda | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 106 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 24 | 21% |
| Student > Master | 15 | 13% |
| Student > Bachelor | 13 | 12% |
| Student > Ph. D. Student | 10 | 9% |
| Student > Doctoral Student | 6 | 5% |
| Other | 18 | 16% |
| Unknown | 26 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 27% |
| Agricultural and Biological Sciences | 10 | 9% |
| Social Sciences | 8 | 7% |
| Business, Management and Accounting | 5 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Other | 22 | 20% |
| Unknown | 32 | 29% |